Fierce Healthcare September 29, 2023
Anastassia Gliadkovskaya

At-home diagnostics startup Viome Life Sciences has launched a new test to help detect oral and throat cancers.

Oral Health Pro with CancerDetect can detect biomarkers associated with oral and throat cancers with a specificity of 95% and sensitivity of 90%, according to clinical validation data recently published by the company. A highly sensitive test means there are few false negatives, while a highly specific test means there are few false positives.

The test is “the most advanced oral and throat cancer screening test available” on the market, per Viome. Patients 50 years or older, or 18 and older who use or have used tobacco products, are eligible for the test.

The vast majority...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Provider
An RNAi renaissance is creating a new generation of startups
Few state Medicaid programs cover GLP-1s for obesity: KFF
STAT+: 7 companies to watch in AI protein design
STAT+: Pharmalittle: We’re reading about Medicaid coverage of obesity drugs, a death in a sickle cell trial, and more
Why Digital Twin Technology Could Help Maximize GLP-1 Efficacy

Share This Article